Point-of-care hematology and coagulation testing in primary, rural emergency, and disaster care scenarios

Point of Care

Volumn 11, Issue 2, 2012, Pages 140-145

  Curtis, Corbin M ^a   Kost, Gerald J ^a   Louie, Richard F ^a   Sonu, Rebecca J ^a   Ammirati, Erika B ^b   Sumner, Stephanie L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Ammirati Regulatory Consultants   (United States)

Author keywords

accuracy; Clinical Laboratory Improvement Amendments of 1988 waiver; clinical needs assessment; confounding factors; Food and Drug Administration

Indexed keywords

EID: 84862162055     PISSN: 1533029X     EISSN: 15330303     Source Type: Journal    
DOI: 10.1097/POC.0b013e31825a9d3a     Document Type: Review

References (31)

1. Food and Drug Administration Guidance Document. Recommendation for Clinical Laboratory Improvement Amendments of 1988 (CLIA) Waiver Applications for Manufacturers of In Vitro Diagnostic Devices January 30, 2008. Available at: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/ GuidanceDocuments/ucm079632.htm. Accessed April 26, 2011.
2. Kost GJ. Principles and Practice of Point-of-Care Testing. Philadelphia PA: Lippincott, Williams, and Wilkins; 2002.
3. Behl D, Hendrickson AQ, Moynihan TJ. Oncologic emergencies. Crit Care Clin. 2010;26:181-205.
4. Huppert J, Hesse E, Gaydos CA. What's the point? How point-of-care STI tests can impact infected patients. Point Care. 2010;9:36-46.
5. ProTime® Microcoagulation System Cuvette Package Insert. Availabl at: http://www.itcmed.com/uploads/literature/ir5259-0208-1.pdf. Accessed April 12, 2012.
6. CoaguChek XS® system - the smart way to test INR at home. CoaguChek Because it'smy life. December 20, 2010. Available at: http:/www.coaguchek.com/ com/index.php?target=/en/professionals/products/coaguchek-xs-system. Accessed April 6, 2012.
7. Ansell J, Hirsh J, Hylek E, et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133:160S-198S. (Pubitemid 351892967)
8. HemoCue Hemoglobin 201+ and 201 DM Systems. Available at: http:/www.hemocue.com/international/Products/Hemoglobin-1155.html. Accessed April 6, 2012.
9. Ojengbede OA, Okonkwo SN, Morhason-Bello IO. Comparative evaluation of haemoglobin estimation amongst pregnant women in Ibadan: HemoCue - B haemoglobin analyzer versus haemiglobincyanid (standard) method as the gold standard. Afr J Reprod Health. 2008;12: 153-159.
10. van den Brule JM, Romkes JH, Brouwer MA, et al. An error in the CoaguChek S® device results in prosthetic heart valve thrombosis. Interact Cardiovasc Thorac Surg. 2010;11:123-124.
11. Rost NS, Masrur S, Pervez MA, et al. Unsuspected coagulopathy rarely prevents IV thrombolysis in acute ischemic stroke. Neurology. 2009;73:1957-1962.
12. Lippi G, Favaloro EJ. Unsuspected coagulopathy rarely prevents IV thrombolysis in acute ischemic stroke. Neurology. 2010;74:1477; author reply 1477-1478.
13. Rizos T, Herweh C, Jenetzky E, et al. Point-of-care international normalized ratio testing accelerates thrombolysis in patients with acute ischemic stroke using oral anticoagulants. Stroke. 2009; 40:3547-3551.
14. Clinical and Laboratory Standards Institute (CLSI). Quantitative D-Dimer for the Exclusion of Venous Thromboembolic Disease; Approved Guideline. CLSI document H59-A. Wayne, PA: CLSI; 2011.
15. Inoue K. Venous thromboembolism in earthquake victims. Disaster Manag Response. 2006;4:25-27. (Pubitemid 43046025)
16. Jackson SL, Peterson GM, House M, et al. Point-of-care monitoring of anticoagulant therapy by rural community pharmacists: description of successful outcomes. Aust J Rural Health. 2004;12:197-200. (Pubitemid 40089905)
17. Gill JM, Landis MK. Benefits of a mobile, point-of-care anticoagulation therapy management program. Jt Comm J Qual Improv. 2002;28: 625-630.
18. Radiation Injury Treatment Network (RITN). Available at: www.ritn.net. Accessed April 5, 2012.
19. US Department of Health and Human Services: Radiation Event Medical Management (REMM). Lymphocyte Depletion Kinetics Graph-Illustration. Available at: http://www.remm.nlm.gov/andrewslymphocytes.htm. Accessed April 5, 2012.
20. Weinstock DM, Case C Jr, Bader JL, et al. Radiologic and nuclear events: contingency planning for hematologists/oncologists. Blood. 2008;111:5440-5445.
21. Brock TK, Mecozzi DM, Sumner S, et al. Evidence-based point-of-care tests and device designs for disaster preparedness. Am J Disaster Med. 2010;5:285-294.
22. Kost GJ, Hale KR, Brock TK, et al. Point-of-care testing for disasters: needs assessment, strategic planning, and future design. Clin Lab Med. 2009;29:583-605.
23. Mecozzi DM, Brock TK, Tran NK, et al. Evidence-based point-of-care device design for emergency and disaster care. Point Care. 2010; 9:65-69.
24. Osei-Bimpong A, Jury C, McLean R, et al. Point-of-care method for total white cell count: an evaluation of the HemoCue WBC device. Int J Lab Hematol. 2009;31:657-664.
25. Stachon A, Segbers E, Holland-Letz T, et al. Nucleated red blood cells in the blood of medical intensive care patients indicate increased mortality risk: a prospective cohort study. Crit Care. 2007;11:R62.
26. Hermansen MC. Nucleated red blood cells in the fetus and newborn. Arch Dis Child Fetal Neonatal Ed. 2001;84:F211-F215. (Pubitemid 32411264)
27. Lichtman MA, Shafer JA, Felgar RE, et al. A Size, chronicity, and shape: normal and abnormal. In: Lichtman MA, Shafer JA, Felgar RE, et al, eds. Lichtman's Atlas of Hematology. New York, NY: McGraw-Hill; 2007. Available at: http://www.accessmedicine.com/content.aspx?aID=2780000. Accessed April 6, 2012.
28. Schaefer M, Rowan RM. The clinical relevance of nucleated red blood cell counts. Sysmex J Int. 2000;10:59-63.
29. Etzell JE. For WBC differentials, report in absolute numbers. March 2010. CAP Today. Available at: http://www.cap.org/apps/cap.portal?-nfpb= true&cntvwrPtlt-actionOverride=%2Fportlets%2FcontentViewer%2Fshow&- windowLabel=cntvwrPtlt&cntvwrPtlt{actionForm.contentReference}= cap-today%2F0310%2F0310d-for-wbc-differentials.html&-state= maximized&-pageLabel=cntvwr. Accessed April 6, 2012.
30. Otsubo H, Kaito K, Asai O, et al. Persistent nucleated red blood cells in peripheral blood is a poor prognostic factor in patients undergoing stem cell transplantation. Clin Lab Haematol. 2005;27:242-246. (Pubitemid 41113496)
31. c·T diff™ Hematology Analyzer Product Brochure. Available at: https://www.beckmancoulter.com/wsrportal/ bibliography?docname=BR-13692A-AcT-diff.pdf. Accessed April 12, 2012.